Device General Surgery

Conmed Hemostasis

Payments companies reported to CMS as associated with Conmed Hemostasis. "Associated with" is CMS's wording: it links a payment to a product without saying the money was spent on it.

$50Kassociated payments (2023-2025)
399clinicians with associated payments
1company reporting

By year

2023 $17K
2024 $19K
2025 $14K

Payments reported as associated with Conmed Hemostasis, per program year, as reported to CMS.

Who makes it

Specialties most often involved

Gastroenterology (Internal Medicine) $43K
Internal Medicine $1,521
Pediatric Gastroenterology $1,306
Family $521
Physician Assistant $467
Surgery $293

Where the associated payments went, by the receiving clinician's specialty.

Clinicians most associated with Conmed Hemostasis

These are the largest totals companies reported as associated with Conmed Hemostasis. They are typically speaking or consulting arrangements, which companies must report by law; appearing here is not evidence of anything improper.

ClinicianLocationSpecialtyAssociated payments (2023-2025)
Jianhua Tau Austin, TX Gastroenterology (Internal Medicine) $7,198.71
Srihari Mahadev New York, NY Gastroenterology (Internal Medicine) $6,135.30
Justin Forde Gainesville, FL Gastroenterology (Internal Medicine) $1,000.68
David Forcione Boston, MA Gastroenterology (Internal Medicine) $782.56
Jorge Suarez Doral, FL Gastroenterology (Internal Medicine) $657.28
Osman Ali Baltimore, MD Gastroenterology (Internal Medicine) $439.73
Kalpesh Patel Houston, TX Gastroenterology (Internal Medicine) $431.19
Parth Parekh New Orleans, LA Gastroenterology (Internal Medicine) $387.83
Sandeep Patel San Antonio, TX Gastroenterology (Internal Medicine) $359.28
Amaninder Jeet Dhaliwal Florence, SC Gastroenterology (Internal Medicine) $353.44

Prescribed Conmed Hemostasis?

See what its makers reported for your doctor. Two steps, private, no account.

Check my doctor

Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.